(Q43748507)

26 November 2017

title

Comment: comparison of FDA reports of patient deaths associated with sildenafil and injectable alprostadil (English)

1 reference

26 November 2017

B L Strom

1

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Annals of Pharmacotherapy

26 November 2017

published in

1 reference

26 November 2017

volume

35

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

1143

1 reference

26 November 2017

cites work

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10218A

The serotonin syndrome and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10218A

Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10218A

Treatment of the serotonin syndrome with cyproheptadine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10218A

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10218A

Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10218A

21 January 2018

Identifiers

DOI

10.1345/APH.10218A

1 reference

26 November 2017

1 reference